Semax research peptide – Semax is a synthetic ACTH(4-7) heptapeptide nootropic that u

Semax

Semax is a synthetic ACTH(4-7) heptapeptide nootropic that upregulates BDNF and NGF for cognitive enhancement and neuroprotection.

Cognitive
In Stock

Total Price

฿700

CardCryptoEncrypted checkout

For research & laboratory use only. Not for human consumption.

Half-Life

~1-7 minutes (intranasal); active metabolites much longer

Administration Route

Intranasal or subcutaneous injection

ACTH Analogue Nootropic

Melanocortin receptor activation enhances focus and cognition

Neuroprotection

Reduces ischaemia damage; used in Russian stroke protocols

BDNF & NGF Release

Triggers neurotrophic factor release for synaptogenesis

Effect Timeline

Start — Days 1–3

Increased focus and mental clarity within first uses

Week 2

Working memory improvement; verbal fluency enhanced

Week 4

BDNF elevation measurable; stress resilience improved

Week 8

Sustained neuroprotective effect; cognitive baseline elevated

Mechanism of Action

Semax is a synthetic heptapeptide built on the ACTH(4-7) fragment (Met-Glu-His-Phe) and extended with a Pro-Gly-Pro tail that resists enzymatic breakdown. Stripping the rest of the adrenocorticotropic hormone removes its cortisol-releasing action while keeping the neurotrophic signalling intact, so Semax raises brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) through melanocortin-receptor-independent pathways. It also lifts dopaminergic and serotonergic tone, boosts vascular endothelial growth factor (VEGF) in neurons and astrocytes, and lowers oxidative-stress markers after ischaemic injury. The combined effect supports synaptic plasticity for cognition and protects neurons in low-oxygen conditions.

Scientific Research

2
Clinical use of Semax in acute ischaemic stroke

Zh Nevrol Psikhiatr Im S S Korsakova (2001)

3
Semax and cognitive function in children with ADHD

Zh Nevrol Psikhiatr Im S S Korsakova (2004)

Why Researchers Choose Semax

Semax is one of the most studied nootropic peptides to come out of Russian neuropharmacology, valued wherever BDNF-driven cognitive enhancement and neuroprotection are the research goal. The Semax 5mg vial, sold singly or in 25mg and 50mg kits, is the standard format for the protocols below.

  • Cognitive enhancement and working-memory research
  • Neuroprotection and acute ischaemic-stroke recovery models
  • BDNF and NGF neurotrophic-signalling studies
  • Dopaminergic and serotonergic pathway investigations
  • Angiogenesis and neuronal survival in hypoxic tissue
  • Stress-resilience and attention-deficit research

Mechanism: Neurotrophic Factor Cascade

BDNF and NGF upregulation: Semax raises both the mRNA and the protein levels of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) across the hippocampus, frontal cortex, and striatum. This neurotrophic support is the central driver behind both the acute cognitive lift and the longer-term neuroprotective effect.

Dopamine and serotonin modulation: Semax activates dopaminergic neurons in the mesocortical and nigrostriatal pathways and strengthens serotonergic transmission. Both systems feed executive function, motivation, and mood.

VEGF upregulation: Under ischaemic stress, Semax increases vascular endothelial growth factor (VEGF) in neurons and astrocytes, which promotes angiogenesis and helps neurons survive in oxygen-starved regions.

Oxidative stress reduction: Semax curbs superoxide dismutase (SOD) consumption and lowers lipid-peroxidation markers after experimental ischaemia.

Stroke Recovery Research

Russian clinical trials reported meaningful gains in neurological outcomes when Semax was given within 12 hours of an acute ischaemic stroke:

  • Quicker recovery of motor function
  • Lower neurological deficit scores
  • Better cognitive performance at three-month follow-up
  • Stronger outcomes at equivalent doses when delivered nasally rather than parenterally

Standard Semax vs N-Acetyl Semax Amidate

FormModificationsRelative PotencyStability
Standard SemaxNoneBaselineModerate
N-Acetyl SemaxN-terminal acetylModerate increaseHigher
N-Acetyl Semax AmidateAcetyl + C-terminal amideSignificant increaseHighest

The acetyl and amidate modifications improve lipophilicity (better CNS penetration) and harden the peptide against enzymatic degradation, which is why the modified forms are reported as more potent per dose.

Reconstitution and Storage

Reconstitution: use sterile or bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: keep refrigerated and use within 30 days.

For research purposes only. Not for human consumption.

Dosing at a Glance

Route

Intranasal or subcutaneous injection

Frequency

1-3x daily (intranasal/SC)

Typical research dose

300–900 mcg

Calculate dosage

Opens the calculator with this peptide preselected. Research reference only.

Product FAQs

Stacks Well With

Used in Research Stacks

Cognitive Focus Stack

Semax 600 mcg Selank 500 mcg
View Stack Research

Related Products

Cart

Your cart is empty